Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme

Conclusion: Epidermal growth factor receptor amplification was not found to be a significant prognostic indicator of overall survival or radiographic local control in patients with GBM treated with surgery at the Cleveland Clinic Foundation. Further studies are needed to fully delineate the significance of this molecular marker in patients with GBM.